Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-coa dehydrogenase deficiency)
- 1 March 1993
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 71 (8) , 738-744
- https://doi.org/10.1016/0002-9149(93)91020-i
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Medium-Chain Acyl-CoA Dehydrogenase DeficiencyNew England Journal of Medicine, 1988
- Medium-chain and long-chain acyl CoA dehydrogenase deficiency: Clinical, pathologic and ultrastructural differentiation from Reye's syndrome†Hepatology, 1986
- Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunctionAmerican Heart Journal, 1986
- Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromesThe Journal of Pediatrics, 1986
- Positron emission tomography of the heartProgress in Cardiovascular Diseases, 1985
- Fluorometric assay of acyl-CoA dehydrogenases in normal and mutant human fibroblastsBiochemical Medicine, 1985
- Short-Chain Acyl-CoA Dehydrogenase Deficiency Associated with a Lipid-Storage Myopathy and Secondary Carnitine DeficiencyNew England Journal of Medicine, 1984
- Remote system for production of carbon-11 labeled palmitic acidJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- Dicarboxylic Aciduria: Deficient [1- 14 C]Octanoate Oxidation and Medium-Chain Acyl-CoA Dehydrogenase in FibroblastsScience, 1983
- C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomographyAmerican Heart Journal, 1982